California Workers’ Compensation Drug List Updated: What Employers and Employees Need to Know
The California Department of Industrial Relations (DIR) has announced an update to the Medical Treatment Utilization Schedule (MTUS) Drug List, effective April 30, 2026. This change, issued by Acting Administrative Director Nicole Richardson, impacts how medications are covered for injured workers in the state.
Understanding the MTUS and its Importance
The MTUS Drug List is a critical component of California’s workers’ compensation system. It dictates which medications are presumed appropriate for treating work-related injuries and illnesses. Updates to the list are based on evolving medical guidelines, ensuring treatments align with current best practices. The latest revisions stem from updates to the American College of Occupational and Environmental Medicine (ACOEM) Practice Guidelines, specifically regarding Traumatic Brain Injury.
Key Changes and What They Mean
The updated MTUS Drug List v.14 incorporates changes based on the ACOEM guidelines published by Reed Group, Ltd. While specific medication changes aren’t detailed in the announcement, the focus on Traumatic Brain Injury suggests potential adjustments to treatments for concussion symptoms, post-concussion syndrome, and related neurological conditions. In other words physicians treating injured workers may see changes in what medications are readily approved.
Pro Tip: Employers should ensure their claims administrators are aware of the updated MTUS Drug List to avoid potential delays or denials in medication coverage for injured employees.
How the Update Impacts Injured Workers
For injured workers, the changes aim to provide access to the most effective and evidence-based treatments. While some medications may be added to the formulary, others might be removed or have their usage restricted. Workers with questions or concerns about their medication coverage should discuss them with their physician and their claims administrator.
Providing Feedback on the Formulary
The DWC actively encourages feedback from stakeholders. Injured workers, physicians, pharmacists, and other interested parties can submit questions, comments, and suggestions to [email protected]. This feedback process is crucial for refining the MTUS and ensuring it meets the needs of the California workers’ compensation system.
The Role of Nicole Richardson and the DWC
Nicole Richardson, Staff Counsel IV at the Division of Workers’ Compensation, is instrumental in overseeing these regulatory updates. Her expertise in regulatory processes and stakeholder relationships is vital to ensuring a smooth transition and effective implementation of the revised MTUS Drug List. The DWC, under her guidance, continues to prioritize the health and safety of California’s workforce.
Frequently Asked Questions
Q: Where can I find the updated MTUS Drug List?
A: The updated list and the Administrative Director Order are available on the DWC MTUS drug formulary webpage.
Q: What is the ACOEM?
A: The American College of Occupational and Environmental Medicine is a professional medical society dedicated to advancing the health and well-being of working populations.
Q: Who should I contact if I have questions about my medication coverage?
A: Contact your physician and your workers’ compensation claims administrator.
Did you know? The California Department of Industrial Relations was established in 1927 and protects over 20 million wage earners in the state.
Stay informed about changes to California’s workers’ compensation system by visiting the California Department of Industrial Relations website. For more information on workers’ rights and safety, explore resources from the Labor & Workforce Development Agency.
Related reading